Search Results 141-150 of 15436 for infliximab

  1. Natalizumab-sztn (intravenous route) - Side effects & uses - Mayo Clinic

    Infliximab; Vedolizumab. Other Interactions. Certain medicines should not be used at or around the time of eating food or eating certain types of food since ...

  2. Brodalumab (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Finerenone; Haloperidol; Infliximab; Influenza Virus Vaccine, Live; Measles Virus Vaccine, Live; Methylergonovine; Mifepristone; Mumps Virus Vaccine, Live ...

  3. 18 Months Later - Your Impact Development

    We did the genetic testing and found out, in fact, Andrew was not able to break down the medications the way most individuals would. Because of this, the ...

  4. Leading the way to the future of healthcare - Mayo Clinic

    Share · Tweet. See also. Abdominal aortic aneurysm · Acne · Actinic keratosis · Atrial septal defect (ASD) · Autoimmune pancreatitis · Back pain ...

  5. Crohn's disease - Doctors and departments - Mayo Clinic

    Departments that treat this condition · Colon and Rectal Surgery · Gastroenterology and Hepatology · Inflammatory Bowel Disease Clinic · Laboratory Medicine and ...

  6. Anti-seizure medications appear to interfere with the overactive transmission of pain signals sent from damaged nerves (neuropathy) or overly sensitized ...

  7. Advancing care for people with Hodgkin lymphoma - Mayo Clinic

    Mayo Clinic doctors are leaders in conducting clinical trials of Hodgkin lymphoma treatments that are more effective and less toxic.

  8. Bacillus of calmette and guerin vaccine, live (intradermal route) - Side effects & dosage - Mayo Clinic

    Infliximab; Ixekizumab; Lebrikizumab-lbkz; Leniolisib; Lovotibeglogene Autotemcel; Mirikizumab-mrkz; Mycophenolate Mofetil; Mycophenolic Acid. Show More. Using ...

  9. Nonalcoholic fatty liver disease - Doctors and departments - Mayo Clinic

    Mayo Clinic investigators are making new discoveries in the areas of cause, prevention and treatment of NAFLD . Their findings are helping to improve patient ...

  10. Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis - Mayo Clinic

    8 week washout for infliximab or adalimumab; 2 week washout for etanercept; 1 week washout for anakinra. If an IS agent is continued, the dose must remain ...